13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001442756
申报总市值
US$11.7亿
US$11.7亿
78 檔
47.1%
在 Q4 2024 的 13F 官方备案中，PFM Health Sciences, LP 管理的美股投资组合规模来到 US$11.7亿，整体持股档数为 78 档。
PFM Health Sciences, LP 在 Q4 2024 进行了结构性的板块轮动与仓位换股。在开立 22 个全新仓位及加仓 10 档持股的同时，亦同步清仓 18 档并减仓 26 档标的。
在资产配置集中度方面，PFM Health Sciences, LP 的前 5 大核心持股（包含 LLY, IEF, EW 等）合计占整体申报市值的 47.1%，反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
IEF
市值: US$9245.0万
本季最大获利了结 / 清仓标的
CYTK
前期市值: US$9278.0万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 股票-医疗保健 | 14.29% | -1.48% | — | |
| 2 | IEF | Ishares 7-10 Year Treasury B | ETF-政府公债 | 5.73% | — | — | |
| 3 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 5.14% | +0.08% | +186.44% | |
| 4 | XLV | Ss Health Care Select Sector | ETF-其他 | 4.68% | -3.19% | EXIT | |
| 5 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 4.17% | +1.72% | +75.81% | |
| 6 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 3.84% | -4.83% | -16.64% | |
| 7 | ABBV | Abbvie Inc | 股票-医疗保健 | 3.65% | — | -17.86% | |
| 8 | MCK | Mckesson CORP | 股票-医疗保健 | 3.44% | — | — | |
| 9 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 3.17% | — | -14.69% | |
| 10 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.01% | — | -32.23% | |
| 11 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 2.45% | +0.54% | — | |
| 12 | PEN | Penumbra Inc | 股票-医疗保健 | 2.45% | -2.56% | — | |
| 13 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 2.43% | +0.06% | -26.64% | |
| 14 | UHS | Universal Health Services-b | 股票-医疗保健 | 2.38% | — | — | |
| 15 | DHR | Danaher CORP | 股票-医疗保健 | 1.79% | — | — | |
| 16 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 1.79% | +0.43% | — | |
| 17 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 1.67% | +1.45% | +10.39% | |
| 18 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.58% | -0.86% | EXIT | |
| 19 | ASND 2.25 04-01-28债券 | Ascendis Pharma A/s | 债券 | 1.57% | -1.54% | EXIT | |
| 20 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.41% | +0.50% | — | |
| 21 | IQV | Iqvia Holdings Inc | 股票-医疗保健 | 1.36% | — | — | |
| 22 | WAT | Waters CORP | 股票-医疗保健 | 1.36% | +0.85% | +15.65% | |
| 23 | IJH | Ishares Core S&p Midcap ETF | ETF-其他 | 1.34% | — | — | |
| 24 | HUM | Humana Inc | 股票-医疗保健 | 1.31% | +3.22% | NEW | |
| 25 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.29% | -0.49% | -44.38% | |
| 26 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 1.26% | — | — | |
| 27 | RSP | Invesco S&p 500 Equal Weight | ETF-大型股与成长 | 1.17% | — | — | |
| 28 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 1.15% | -4.03% | — | |
| 29 | KWEB | Kranesh Csi China Internet | ETF-新兴市场 | 1.12% | — | — | |
| 30 | CAH | Cardinal Health Inc | 股票-医疗保健 | 1.09% | -0.62% | EXIT | |
| 31 | BHVN | Biohaven Ltd. | 股票-其他 | 1.00% | — | — | |
| 32 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 1.00% | -5.30% | EXIT | |
| 33 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 0.86% | -0.76% | EXIT | |
| 34 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 0.75% | — | +13.55% | |
| 35 | IWM | Ishares Russell 2000 ETF | ETF-中小型股 | 0.75% | — | — | |
| 36 | SYK | Stryker CORP | 股票-医疗保健 | 0.72% | +0.87% | -51.73% | |
| 37 | VEEV | Veeva Systems Inc-class A | 股票-医疗保健 | 0.72% | — | +187.57% | |
| 38 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 0.72% | +0.75% | — | |
| 39 | ERAS | Erasca Inc | 股票-其他 | 0.68% | +0.21% | NEW | |
| 40 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.68% | +0.57% | -63.99% | |
| 41 | BBIO | Bridgebio Pharma Inc | 股票-医疗保健 | 0.58% | -0.13% | — | |
| 42 | PRAX | Praxis Precision Medicines I | 股票-其他 | 0.57% | +0.07% | -34.73% | |
| 43 | CNC | Centene CORP | 股票-医疗保健 | 0.54% | +1.07% | — | |
| 44 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 0.54% | — | — | |
| 45 | SRPT 1.25 09-15-27债券 | Sarepta Therapeutics Inc | 债券 | 0.53% | — | — | |
| 46 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 0.45% | — | — | |
| 47 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.45% | -3.64% | EXIT | |
| 48 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 0.39% | -1.91% | EXIT | |
| 49 | CRBU | Caribou Biosciences Inc | 股票-其他 | 0.38% | -0.12% | -9.99% | |
| 50 | SWTXUSD | Springworks Therapeutics Inc | 股票-其他 | 0.34% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | IEF | Ishares 7-10 Year Treasury B | +5.7% | NEW | 新建仓 |
| 2 | XLV | Ss Health Care Select Sector | +4.7% | NEW | 新建仓 |
| 3 | EW | Edwards Lifesciences CORP | +3.7% | +186.44% | 加仓 |
| 4 | NVO | Novo-nordisk A/s-spons Adr | +1.8% | NEW | 新建仓 |
| 5 | UNH | Unitedhealth Group Inc | +1.7% | +75.81% | 加仓 |
| 6 | DXCM | Dexcom Inc | +1.6% | NEW | 新建仓 |
| 7 | NBIX | Neurocrine Biosciences Inc | +1.4% | NEW | 新建仓 |
| 8 | IJH | Ishares Core S&p Midcap ETF | +1.3% | NEW | 新建仓 |
| 9 | RSP | Invesco S&p 500 Equal Weight | +1.2% | NEW | 新建仓 |
| 10 | UTHR | United Therapeutics CORP | +1.2% | NEW | 新建仓 |
| 11 | KWEB | Kranesh Csi China Internet | +1.1% | NEW | 新建仓 |
| 12 | CAH | Cardinal Health Inc | +1.1% | NEW | 新建仓 |
| 13 | BHVN | Biohaven Ltd. | +1% | NEW | 新建仓 |
| 14 | SLNOEUR | Soleno Therapeutics Inc | +0.9% | NEW | 新建仓 |
| 15 | IWM | Ishares Russell 2000 ETF | +0.8% | NEW | 新建仓 |
| 16 | MCK | Mckesson CORP | +0.7% | — | 不变 |
| 17 | PEN | Penumbra Inc | +0.6% | — | 不变 |
| 18 | BBIO | Bridgebio Pharma Inc | +0.6% | NEW | 新建仓 |
| 19 | CNC | Centene CORP | +0.5% | NEW | 新建仓 |
| 20 | TEVA | Teva Pharmaceutical-sp Adr | +0.5% | NEW | 新建仓 |
| 21 | VEEV | Veeva Systems Inc-class A | +0.5% | +187.57% | 加仓 |
| 22 | SPY | Ss Spdr S&p 500 ETF Trust-us | +0.5% | NEW | 新建仓 |
| 23 | SWTXUSD | Springworks Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 24 | WAT | Waters CORP | +0.3% | +15.65% | 加仓 |
| 25 | QURE | uniQure N.V. | +0.3% | +132.81% | 加仓 |
| 26 | BNTX | Biontech Se-adr | +0.2% | NEW | 新建仓 |
| 27 | 2655787D | Blueprint Medicines CORP | +0.2% | NEW | 新建仓 |
| 28 | 260 | Centessa Pharmaceuticals-adr | +0.2% | +38.12% | 加仓 |
| 29 | JAZZ | Jazz Pharmaceuticals plc | +0.1% | NEW | 新建仓 |
| 30 | SRPT | Sarepta Therapeutics Inc | +0.1% | +13.55% | 加仓 |
| 31 | SGMT | Sagimet Biosciences Inc-a | +0.1% | — | 不变 |
| 32 | AXSM | Axsome Therapeutics Inc | +0.1% | — | 不变 |
| 33 | MGX | Metagenomi Therapeutics Inc | +0.1% | -14.33% | 减仓 |
| 34 | ASND 2.25 04-01-28债券 | Ascendis Pharma A/s | +0.1% | — | 不变 |
| 35 | BLE0 | Bluebird Bio Inc | 0% | NEW | 新建仓 |
| 36 | SRPT 1.25 09-15-27债券 | Sarepta Therapeutics Inc | 0% | — | 不变 |
| 37 | PMVP | Pmv Pharmaceuticals Inc | 0% | +3.39% | 加仓 |
| 38 | ✓ | Verve Therapeutics Inc | 0% | — | 不变 |
| 39 | INBX | Inhibrx Biosciences Inc | 0% | — | 不变 |
| 40 | ✓ | Turnstone Biologics CORP | — | — | 不变 |
| 41 | IOBTQ | Io Biotech Inc | 0% | — | 不变 |
| 42 | IOVA | Iovance Biotherapeutics Inc | 0% | — | 不变 |
| 43 | BOLD | Boundless Bio Inc | 0% | — | 不变 |
| 44 | ACLXGBX | Arcellx Inc | 0% | -6.60% | 减仓 |
| 45 | PRAX | Praxis Precision Medicines I | 0% | -34.73% | 减仓 |
| 46 | CMPS | Compass Pathways PLC | -0.1% | — | 不变 |
| 47 | GBIOGBX | Generation Bio Co | -0.1% | — | 不变 |
| 48 | ERAS | Erasca Inc | -0.1% | -9.98% | 减仓 |
| 49 | CAPR | Capricor Therapeutics Inc | -0.1% | -64.42% | 减仓 |
| 50 | CRBU | Caribou Biosciences Inc | -0.1% | -9.99% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，PFM Health Sciences, LP 在 Q4 2024 季度的美股持仓总市值约为 US$11.7亿，共申报了 78 个公开持股仓位。
在 Q4 2024 季度，PFM Health Sciences, LP 按市值排列的前三大核心持股分别为：LLY (14.3%)、IEF (5.7%)、EW (5.1%)。其中最大持股仓位 LLY 占据整体投资组合约 14.3% 的权重。
在 Q4 2024 季度中，PFM Health Sciences, LP 共进行了 76 项持仓异动，包含新建仓 22 个仓位、加仓 10 个仓位、减仓 26 个仓位以及清仓 18 个仓位。 其中最大新建仓标的为 IEF。 本季清仓仓位包含 CYTK。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。